• Read more about Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe Respiratory Syncytial Virus (RSV) Infection 

Effective March 11, 2022, MaineCare will no longer accept Prior Authorization (PA) requests for palivizumab for the treatment of RSV. Scheduled doses will be covered through March 31, 2022. and no further shipments will be authorized after March 31, 2022.  

• Read more about Nursing Facility (NF) and Residential Care Facility (PNMI Appendix C) Rates are Available for Billing 

Effective Wednesday, March 9, 2022, we have updated the rates for Sections 67, Nursing Facility and 97, Appendix C Residential Care Facility (RCF) in MIHMS retroactively to January 1, 2022.

• Read more about Notice of Agency Rule-making Adoption: 10-144 C.M.R. Chapter 101, MaineCare Benefits Manual, Section 97, Private Non-Medical Institution Services, Ch. III

AGENCY:  Department of Health and Human Services, Office of MaineCare Services

• Read more about System Maintenance from March 19, 2022 to March 20, 2022   

MIHMS and the Health PAS Online Portal will be unavailable from 12:00 pm on Saturday, March 19, 2022 to 12:00 pm Sunday, March 20, 2022 for scheduled system maintenance and upgrades.  

While the Health PAS Online Portal is unavailable, providers and billing agents will be unable to: 

• Read more about Use of Varenicline and Nicotine Replacement Therapy for Tobacco Cessation 

Use of Varenicline and Nicotine Replacement Therapy for Tobacco Cessation 

• Read more about Use of Varenicline and Nicotine Replacement Therapy for Tobacco Cessation 

Use of Varenicline and Nicotine Replacement Therapy for Tobacco Cessation

• Read more about Use of Varenicline and Nicotine Replacement Therapy for Tobacco Cessation 

Effective February 18, 2022, MaineCare covers the use of varenicline and nicotine replacement therapies prescribed together for tobacco cessation and will cover prescriptions for both products for a member, regardless of the member’s prescription history.

• Read more about No Prior Authorization (PA) Needed for Insulin Used to Treat Gestational Diabetes   

MaineCare will reimburse providers for Humulin and Novolin Neutral Protamine Hagedorn (NPH) insulin for gestational diabetes without a PA when providers indicate pregnancy on the prescription.

• Read more about No Prior Authorization (PA) Needed for Insulin Used to Treat Gestational Diabetes  

MaineCare will reimburse providers for Humulin and Novolin Neutral Protamine Hagedorn (NPH) insulin for gestational diabetes without a PA when providers indicate pregnancy on the prescription.

• Read more about No Prior Authorization (PA) Needed for Insulin Used to Treat Gestational Diabetes

MaineCare will reimburse providers for Humulin and Novolin Neutral Protamine Hagedorn (NPH) insulin for gestational diabetes without a PA when providers indicate pregnancy on the prescription.